Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Gastro Hep Advances is Scopus-indexed (Q2, CiteScore 2.7), WoS ESCI, DOAJ. Published by American Gastroenterological Association.
Checked against the index lists dated .
ISSN 2772-5723Verify ISSN ↗
Publisher: American Gastroenterological Association
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 216 / 466 | 53rd | Q2 |
| Gastroenterology | 100 / 176 | 43rd | Q3 |
| Hepatology | 53 / 88 | 40th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 2.7.
Gastro Hep Advances is Q2 in Medicine (miscellaneous) (rank 216 of 466), Q3 in Gastroenterology (rank 100 of 176) and Q3 in Hepatology (rank 53 of 88), by CiteScore 2025.
Gastro Hep Advances is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.694, quartile Q2, with an H-index of 16.
The publisher lists an article processing charge of about US$2,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Gastro Hep Advances is published by American Gastroenterological Association. Its ISSN is 2772-5723.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Gastro Hep Advances has an h-index of 22 and a 2-year mean of 1.69 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q2. On 2-year citations it ranks #190 of 451 Scopus journals in Medicine (miscellaneous).
Gastro Hep Advances published 248 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from United States (61.3%), Japan (9.6%) and Canada (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.